Evette Kingcaid
Family Medicine · Sugar Land, TXNPI 1568540052
Payments from drug & device makers
Across 153 payments — averaging $28.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$827
- Novo Nordisk$437
- Lilly USA, LLC$423
- Bayer$420
- GSK$315
- Amgen$285
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,404100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $827 |
| Novo Nordisk | 22 | $437 |
| Lilly USA, LLC | 18 | $423 |
| Bayer | 15 | $420 |
| GSK | 17 | $315 |
| Amgen | 10 | $285 |
| Mylan Specialty L.p. | 13 | $284 |
| Inspire Medical Systems, Inc. | 3 | $180 |
| Abbott | 5 | $180 |
| Astellas Pharma US Inc | 3 | $144 |
| Idorsia Pharmaceuticals US Inc | 1 | $123 |
| Corcept Therapeutics | 2 | $113 |
| Boehringer Ingelheim | 4 | $102 |
| Paratek Pharmaceuticals, Inc. | 1 | $96 |
| United Therapeutics Corporation | 2 | $86 |
| Exact Sciences | 3 | $56 |
| Pfizer | 3 | $50 |
| Dexcom, Inc. | 2 | $37 |
| Amarin Pharma, Inc. | 2 | $34 |
| Merck | 1 | $34 |
| Medtronic | 1 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| GRT US Holding, Inc. | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Nevro Corp. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$472
- Inspire Upper Airway Stimulation System$145
- MOUNJARO$125
- Veozah$125
- FREESTYLE LIBRE 3$124
- QUVIVIQ$123
- Kerendia$121
- Repatha$119
- BREZTRI$111
How this compares
$4,404 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 31 | $29,789 |
| MounjaroTirzepatide | 19 | $21,955 |
| JardianceEmpagliflozin | 23 | $20,742 |
| FarxigaDapagliflozin Propanediol | 24 | $20,118 |
| OzempicSemaglutide | 11 | $15,655 |
| XareltoRivaroxaban | 16 | $11,519 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $3,979 |
| Atorvastatin Calcium | 312 | $3,798 |
| Rosuvastatin Calcium | 115 | $2,356 |
| Metoprolol Succinate | 79 | $1,494 |
| Levothyroxine Sodium | 159 | $1,474 |
| Montelukast Sodium | 63 | $969 |
| Amlodipine Besylate | 139 | $942 |
| Omeprazole | 54 | $933 |
| Losartan Potassium | 67 | $909 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $50 | $29,78931 claims |
| Lilly USA, LLCMounjaro | $423 | $21,95519 claims |
| Boehringer IngelheimJardiance | $102 | $20,74223 claims |
| AstraZenecaFarxiga | $827 | $20,11824 claims |
| Novo NordiskOzempic | $437 | $15,65511 claims |
| Johnson & JohnsonXarelto | $12 | $11,51916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Sugar Land
- Wilner JeudySugar Land$6M
- Ronald PucilloSugar Land$5.1M
- Mehjabin ParkarSugar Land$3.9M
- John VanderzylSugar Land$3.8M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.